Protective role of neuronal and lymphoid cannabinoid CB


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
20 07 2020
Historique:
received: 29 01 2020
accepted: 19 07 2020
pubmed: 21 7 2020
medline: 17 2 2021
entrez: 21 7 2020
Statut: epublish

Résumé

Cannabinoid CB

Identifiants

pubmed: 32687056
doi: 10.7554/eLife.55582
pii: 55582
pmc: PMC7384863
doi:
pii:

Substances chimiques

Cannabinoid Receptor Agonists 0
Cannabinoids 0
Protective Agents 0
Receptors, Cannabinoid 0
1,1-dimethylbutyl-1-deoxy-Delta(9)-THC TDG8048RDA

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Commission
ID : FP7-602891-2
Pays : International
Organisme : Instituto de Salud Carlos III
ID : RD12/0028/0023/FEDER
Pays : International
Organisme : Ministerio de Economía y Competitividad
ID : SAF2014-59648-P
Pays : International
Organisme : Generalitat de Catalunya
ID : 2014-SGR-1547
Pays : International
Organisme : Generalitat de Catalunya
ID : 2018 FI_B 00207
Pays : International
Organisme : Polish Ministry of Science and Education
ID : 3070/7.PR/2014/2
Pays : International
Organisme : Universidad Miguel Hernandez
ID : UMH-PAR2019
Pays : International
Organisme : Spanish Ministry of Science, Innovation and Universities
ID : RTI2018-097189-B-C21
Pays : International
Organisme : Instituto de Salud Carlos III
ID : RTA, RD16/0017/0020
Pays : International
Organisme : Ministerio de Ciencia e Innovación
ID : SAF2017-84060-R-AEI/FEDER-UE
Pays : International
Organisme : Generalitat de Catalunya
ID : SGR2017-669
Pays : International

Informations de copyright

© 2020, Cabañero et al.

Déclaration de conflit d'intérêts

DC, AR, ED, AS, DO, AW, HH, SK, AF, RP, AZ, RM No competing interests declared

Références

Pain. 2015 Oct;156(10):2001-12
pubmed: 26067584
Neuron. 2016 May 18;90(4):670-1
pubmed: 27196970
PLoS One. 2015 Sep 25;10(9):e0138986
pubmed: 26406232
Neurobiol Dis. 1998 Dec;5(6 Pt B):483-501
pubmed: 9974180
J Neurosci Methods. 1994 Jul;53(1):55-63
pubmed: 7990513
Nature. 2019 Jan;565(7737):86-90
pubmed: 30532001
J Neuroinflammation. 2018 May 24;15(1):158
pubmed: 29793509
J Pain. 2004 Nov;5(9):491-7
pubmed: 15556827
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Behav Pharmacol. 2007 Nov;18(7):691-7
pubmed: 17912054
PLoS Biol. 2014 Jun 03;12(6):e1001874
pubmed: 24893313
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12525-30
pubmed: 16116088
Nat Rev Neurosci. 2016 Mar;17(3):160-72
pubmed: 26891626
Blood. 2006 May 15;107(10):3925-32
pubmed: 16418326
J Psychopharmacol. 2012 Jan;26(1):92-103
pubmed: 21447538
Eur J Pain. 2013 Jul;17(6):832-43
pubmed: 23172791
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10529-33
pubmed: 12917492
Nature. 2018 Mar 29;555(7698):662-666
pubmed: 29539642
Neurobiol Aging. 2015 Feb;36(2):710-9
pubmed: 25443294
Sci Rep. 2018 Jul 17;8(1):10827
pubmed: 30018366
Pain. 1998 May;76(1-2):215-22
pubmed: 9696476
Eur J Pharmacol. 2000 May 19;396(2-3):141-9
pubmed: 10822068
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):E5007-15
pubmed: 25368177
Trends Pharmacol Sci. 2007 Jan;28(1):39-45
pubmed: 17141334
Pain. 2011 Sep;152(9):1976-87
pubmed: 21550725
Neuron. 2006 Apr 20;50(2):277-89
pubmed: 16630838
Nat Rev Neurosci. 2009 Apr;10(4):283-94
pubmed: 19259101
J Neurosci. 2015 Sep 2;35(35):12217-31
pubmed: 26338332
Semin Cell Dev Biol. 2016 Dec;60:146-154
pubmed: 27375226
Pain. 2014 Nov;155(11):2377-89
pubmed: 25218828
Pain. 2018 May;159(5):819-824
pubmed: 29300280
Nature. 1993 Sep 2;365(6441):61-5
pubmed: 7689702
Int J Neurosci. 2017 Sep;127(9):812-823
pubmed: 27842450
J Neuroinflammation. 2017 Feb 6;14(1):30
pubmed: 28166793
Pain. 1988 Jan;32(1):77-88
pubmed: 3340425
Br J Pharmacol. 2014 Jun;171(12):2951-63
pubmed: 24527763
J Clin Invest. 2009 Feb;119(2):278-86
pubmed: 19139563
Pain. 2015 Apr;156 Suppl 1:S104-14
pubmed: 25789426
Pain. 2016 Feb;157 Suppl 1:S23-32
pubmed: 26785153
Eur J Pain. 2018 Apr;22(4):763-773
pubmed: 29280233
Biochem Pharmacol. 2018 Nov;157:108-121
pubmed: 30217570
J Neurosci. 2008 Nov 12;28(46):12125-35
pubmed: 19005077
Brain Behav Immun. 2016 Oct;57:227-242
pubmed: 27139929
J Clin Invest. 2016 Feb;126(2):745-61
pubmed: 26752644
Neuron. 2016 May 18;90(4):795-809
pubmed: 27133464
Nature. 2003 Oct 30;425(6961):968-73
pubmed: 14555960
Immunol Res. 2016 Dec;64(5-6):1216-1224
pubmed: 27677768
Br J Pharmacol. 2008 Jan;153(2):358-66
pubmed: 17982474
Nature. 2017 Feb 23;542(7642):479-483
pubmed: 28192788
J Neurosci. 2012 Mar 21;32(12):4004-16
pubmed: 22442067
Pain. 2010 Oct;151(1):12-7
pubmed: 20696526
Eur J Immunol. 2016 Jun;46(6):1340-2
pubmed: 27198084
Eur Neuropsychopharmacol. 2017 Dec;27(12):1185-1215
pubmed: 28988943
PLoS Pathog. 2016 May 11;12(5):e1005615
pubmed: 27168185
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
Nat Commun. 2017 Jan 03;8:13958
pubmed: 28045021
Neuropsychopharmacology. 2005 Sep;30(9):1670-80
pubmed: 15742004
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525-30
pubmed: 17686976
Curr Opin Anaesthesiol. 2018 Aug;31(4):407-414
pubmed: 29794855
Neurosci Biobehav Rev. 2011 Jan;35(3):912-38
pubmed: 21036191
J Immunol. 2012 Mar 1;188(5):2179-88
pubmed: 22279104

Auteurs

David Cabañero (D)

Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Institute of Research, Development and Innovation in Healthcare Biotechnology of Elche (IDiBE), Universidad Miguel Hernández de Elche, Alicante, Spain.

Angela Ramírez-López (A)

Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

Eva Drews (E)

Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.

Anne Schmöle (A)

Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.

David M Otte (DM)

Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.

Agnieszka Wawrzczak-Bargiela (A)

Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.

Hector Huerga Encabo (H)

Immunology Unit, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom.

Sami Kummer (S)

Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

Antonio Ferrer-Montiel (A)

Institute of Research, Development and Innovation in Healthcare Biotechnology of Elche (IDiBE), Universidad Miguel Hernández de Elche, Alicante, Spain.

Ryszard Przewlocki (R)

Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.

Andreas Zimmer (A)

Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany.

Rafael Maldonado (R)

Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH